Who owns Moderna, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MRNA from SEC Form 13F filings across 776 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 776 institutions disclosed 318.6M shares of Moderna, Inc. worth $22.29B — about 80.1% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
776
13F holders
$22.29B
value, 2026 filers
80.1%
of shares outstanding (318.6M sh)
158
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of MRNA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 51.9M | $3.63B | 0.2% | 13% | +13.5% |
| 2 | BlackRock, Inc. | 30.6M | $2.14B | 0.0% | 7.7% | +3.3% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 23.2M | $1.63B | 0.0% | 5.8% | +1.5% |
| 4 | Capital World Investors | 22.3M | $1.56B | 0.2% | 5.6% | +19.1% |
| 5 | BAILLIE GIFFORD & CO | 18.2M | $1.28B | 1.2% | 4.6% | -8.9% |
| 6 | STATE STREET CORP | 15.7M | $1.10B | 0.0% | 4% | +5.8% |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | 15.6M | $1.09B | 0.0% | 3.9% | -0.2% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 9.7M | $678.8M | 0.0% | 2.4% | +2.9% |
| 9 | MORGAN STANLEY | 9.5M | $668.0M | 0.0% | 2.4% | +12.6% |
| 10 | Theleme Partners LLP | 8.1M | $564.3M | 33.5% | 2% | +0.1% |
| 11 | TWO SIGMA INVESTMENTS, LP | 7.2M | $503.8M | 0.4% | 1.8% | -20.8% |
| 12 | Invesco Ltd. | 5.8M | $404.8M | 0.0% | 1.5% | +20.8% |
| 13 | PRICE T ROWE ASSOCIATES INC /MD/ | 5.6M | $391.4M | 0.0% | 1.4% | +656.8% |
| 14 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 4.8M | $338.9M | 0.0% | 1.2% | +2.2% |
| 15 | GOLDMAN SACHS GROUP INC | 4.7M | $327.2M | 0.0% | 1.2% | -29.3% |
| 16 | Flagship Pioneering, LLC | 4.6M | $324.4M | 21.1% | 1.2% | 0.0% |
| 17 | UBS Group AG | 4.5M | $312.6M | 0.0% | 1.1% | +1.3% |
| 18 | BNP PARIBAS FINANCIAL MARKETS | 4.4M | $306.5M | 0.1% | 1.1% | +1.4% |
| 19 | NORGES BANKNEW | 3.0M | $211.9M | 0.0% | 0.8% | new |
| 20 | NORTHERN TRUST CORP | 3.0M | $209.1M | 0.0% | 0.8% | +1.1% |
| 21 | BANQUE PICTET & CIE SA | 2.7M | $189.0M | 1.2% | 0.7% | -1.8% |
| 22 | DIMENSIONAL FUND ADVISORS LP | 2.5M | $172.9M | 0.0% | 0.6% | +15.8% |
| 23 | WELLINGTON MANAGEMENT GROUP LLP | 2.5M | $172.4M | 0.0% | 0.6% | +4.4% |
| 24 | Merck & Co., Inc. | 2.3M | $161.6M | 30.7% | 0.6% | 0.0% |
| 25 | CITIGROUP INC | 2.2M | $151.6M | 0.1% | 0.5% | +46.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.